Highline Wealth Partners’s Boston Scientific BSX Stock Holding History

Highline Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2K	Buy	262 +24	+10%	+$1.3K	﹤0.01%	548
2026 Q1	$14.9K	Buy	238 +35	+17%	+$2.8K	﹤0.01%	357
2025 Q4	$19.4K	Sell	203 -24	-11%	-$2.35K	0.01%	267
2025 Q3	$22.2K	Buy	227 +52	+30%	+$5.38K	0.01%	257
2025 Q2	$18.8K	Sell	175 -50	-22%	-$5.06K	0.01%	233
2025 Q1	$22.7K	Buy	225 +82	+57%	+$8.26K	0.01%	193
2024 Q4	$12.8K	Buy	143 +13	+10%	+$1.14K	﹤0.01%	215
2024 Q3	$10.9K	Buy	130 +46	+55%	+$3.63K	﹤0.01%	242
2024 Q2	$6.47K	Buy	84 +14	+20%	+$1.02K	﹤0.01%	262
2024 Q1	$4.79K	Hold	70	–	–	﹤0.01%	275
2023 Q4	$4.05K	Hold	70	–	–	﹤0.01%	257
2023 Q3	$3.7K	Hold	70	–	–	﹤0.01%	239
2023 Q2	$3.79K	Hold	70	–	–	﹤0.01%	191
2023 Q1	$3.5K	Hold	70	–	–	﹤0.01%	193
2022 Q4	$3.24K	Hold	70	–	–	﹤0.01%	191
2022 Q3	$2.71K	Buy	+70	New	+$2.81K	﹤0.01%	196

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Highline Wealth Partners's BSX Position: Q2 2026 in Review

Highline Wealth Partners increased its Boston Scientific (BSX) stake by 10% in Q2 2026, buying an estimated $1.3K and bringing the position to 262 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Highline Wealth Partners first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.7K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Highline Wealth Partners held 262 shares of Boston Scientific worth $11.2K as of Q2 2026.
Highline Wealth Partners bought 24 Boston Scientific shares in Q2 2026, an estimated $1.3K.
Boston Scientific made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #548 holding.
Highline Wealth Partners first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
Highline Wealth Partners's Boston Scientific position peaked at $22.7K in Q1 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.